Literature DB >> 16493538

Axillary recurrence after negative sentinel node biopsy in a patient with breast cancer: report of a case.

Kazuyoshi Motomura1, Chiyomi Egawa, Yoshifumi Komoike, Yoshihisa Hasegawa, Hiroki Koyama, Hideo Inaji.   

Abstract

We report a case of axillary recurrence after sentinel node biopsy without axillary lymph node dissection in a patient with breast cancer. A hot and dye-stained node was identified at the primary operation and then at the time of axillary recurrence. Sentinel node biopsy is a promising alternative to axillary lymph node dissection in patients with breast cancer because of the low associated incidence of axillary recurrence.

Entities:  

Mesh：

Year:  2006        PMID： 16493538     DOI： 10.1007/s00595-005-3149-6

Source DB:  PubMed          Journal:  Surg Today        ISSN： 0941-1291            Impact factor:   2.549


  8 in total

1.  Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.

Authors:  C E Cox; S Pendas; J M Cox; E Joseph; A R Shons; T Yeatman; N N Ku; G H Lyman; C Berman; F Haddad; D S Reintgen
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

2.  Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.

Authors:  R M Roumen; G P Kuijt; I H Liem; M W van Beek
Journal:  Br J Surg       Date:  2001-12       Impact factor: 6.939

3.  Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients.

Authors:  K Motomura; H Inaji; Y Komoike; Y Hasegawa; T Kasugai; S Noguchi; H Koyama
Journal:  J Surg Oncol       Date:  2001-02       Impact factor: 3.454

4.  Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.

Authors:  A E Giuliano; P I Haigh; M B Brennan; N M Hansen; M C Kelley; W Ye; E C Glass; R R Turner
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

5.  The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures.

Authors:  Arpana M Naik; Jane Fey; Mary Gemignani; Alexandra Heerdt; Leslie Montgomery; Jeanne Petrek; Elisa Port; Virgilio Sacchini; Lisa Sclafani; Kimberly VanZee; Raquel Wagman; Patrick I Borgen; Hiram S Cody
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

6.  Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients.

Authors:  Kazuyoshi Motomura; Yoshifumi Komoike; Yoshihisa Hasegawa; Tsutomu Kasugai; Hideo Inaji; Shinzaburo Noguchi; Hiroki Koyama
Journal:  J Surg Oncol       Date:  2003-02       Impact factor: 3.454

Review 7.  Axillary lymph nodes and breast cancer: a review.

Authors:  A Recht; M J Houlihan
Journal:  Cancer       Date:  1995-11-01       Impact factor: 6.860

8.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

Authors:  Umberto Veronesi; Giovanni Paganelli; Giuseppe Viale; Alberto Luini; Stefano Zurrida; Viviana Galimberti; Mattia Intra; Paolo Veronesi; Chris Robertson; Patrick Maisonneuve; Giuseppe Renne; Concetta De Cicco; Francesca De Lucia; Roberto Gennari
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.